Drug
Tnf Antagonist
Tnf Antagonist: highest development phase Post-Market, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| TNF Antagonist (enbrel, humire, remicade, cimzia, symponi) NCT02353780 | Post-Market | Rheumatoid Arthritis (RA) |
Latest
No recent events.
Follow Tnf Antagonist on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.